Stem cell therapy for the spinal cord

Stem Cell Research and Therapy

Volumn 3, Issue 4, 2012, Pages

  Donnelly, Eleanor M ^a   Lamanna, Jason ^a   Boulis, Nicholas M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL LABELING; CELL TRACKING; CLINICAL EFFECTIVENESS; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MOTOR NEURON DISEASE; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; SPINAL CORD DISEASE; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; ANIMAL; BIOLOGICAL THERAPY; CLINICAL TRIAL (TOPIC); CYTOLOGY; DISEASE MODEL; SPINAL CORD INJURIES; STEM CELL;

ANIMALIA; RODENTIA;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; HUMANS; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84863695370     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt115     Document Type: Review

References (71)

1. Human embryonic stem cells: derivation, culture, and differentiation: a review. Vazin T, Freed WJ, Restor Neurol Neurosci 2010 28 589 603 20714081
2. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Murry CE, Keller G, Cell 2008 132 661 680 10.1016/j.cell.2008.02.008 18295582 (Pubitemid 351260059)
3. Human neural stem cells genetically modified for brain repair in neurological disorders. Kim SU, Neuropathology 2004 24 159 171 10.1111/j.1440-1789.2004.00552.x 15484694 (Pubitemid 39279676)
4. Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Xu L, Yan J, Chen D, Welsh AM, Hazel T, Johe K, Hatfield G, Koliatsos VE, Transplantation 2006 82 865 875 17038899 (Pubitemid 44564030)
5. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. Caplan AI, J Cell Physiol 2007 213 341 347 10.1002/jcp.21200 17620285 (Pubitemid 47509711)
6. Induced pluripotent stem cells and promises of neuroregenerative medicine. Verma A, Verma N, Neurol India 2011 59 555 557 10.4103/0028-3886.84337 21891933
7. Neural stem cell niches and homing: recruitment and integration into functional tissues. Garzon-Muvdi T, Quinones-Hinojosa A, ILAR J 2009 51 3 23 20075495
8. Perinatal sources of mesenchymal stem cells: Wharton's jelly, amnion and chorion. Witkowska-Zimny M, Wrobel E, Cell Mol Biol Lett 2011 16 493 514 10.2478/s11658-011-0019-7 21786036
9. Geron Cell Therapy. http://cell-therapies.geron.com/
10. Memorial Hermann. http://www.memorialhermann.org
11. NIH Clinical Trials Database. http://clinicaltrials.gov
12. Neuralstem. http://www.neuralstem.com
13. Brainstorm Cell Therapeutics. http://www.brainstorm-cell.com
14. TCA Cellular Therapy. http://www.tcacellulartherapy.com
15. California Stem Cell, Inc. http://californiastemcell.com
16. Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord. Himes BT, Neuhuber B, Coleman C, Kushner R, Swanger SA, Kopen GC, Wagner J, Shumsky JS, Fischer I, Neurorehabil Neural Repair 2006 20 278 296 10.1177/1545968306286976 16679505
17. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. Suzuki M, McHugh J, Tork C, Shelley B, Klein S, Aebischer P, Svendsen C, PLoS ONE 2007 2 689 10.1371/journal.pone.0000689 17668067 (Pubitemid 351325410)
18. Research Ethics and Stem Cells. http://stemcells.nih.gov/info/ethics.asp
19. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial. Mazzini L, Ferrero I, Luparello V, Rustichelli D, Gunetti M, Mareschi K, Testa L, Stecco A, Tarletti R, Miglioretti M, Fava E, Nasuelli N, Cisari C, Massara M, Vercelli R, Oggioni GD, Carriero A, Cantello R, Monaco F, Fagioli F, Exp Neurol 2010 223 229 237 10.1016/j.expneurol.2009.08. 007 19682989
20. Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study. Mazzini L, Mareschi K, Ferrero I, Miglioretti M, Stecco A, Servo S, Carriero A, Monaco F, Fagioli F, Cytotherapy 2011 14 56 60 21954839
21. Stem cell treatment in amyotrophic lateral sclerosis. Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Nasuelli N, Oggioni GD, Testa L, Fagioli F, J Neurol Sci 2008 265 78 83 10.1016/j.jns.2007.05.016 17582439
22. Stem Cells Inc. http://www.stemcellsinc.com
23. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1/CXC chemokine receptor 4 pathway. Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD, Frenkel D, Li J, Sidman RL, Walsh CA, Snyder EY, Khoury SJ, Proc Natl Acad Sci USA 2004 101 18117 18122 10.1073/pnas.0408258102 15608062 (Pubitemid 40054083)
24. Functional recovery of chronic paraplegic pigs after autologous transplantation of bone marrow stromal cells. Zurita M, Vaquero J, Bonilla C, Santos M, De Haro J, Oya S, Aguayo C, Transplantation 2008 86 845 853 10.1097/TP.0b013e318186198f 18813110
25. Clinical canine spinal cord injury provides an opportunity to examine the issues in translating laboratory techniques into practical therapy. Jeffery ND, Smith PM, Lakatos A, Ibanez C, Ito D, Franklin RJ, Spinal Cord 2006 44 584 593 10.1038/sj.sc.3101912 16520817 (Pubitemid 44600320)
26. + cells' migration into the injured site. Callera F, de Melo CM, Stem Cells Dev 2007 16 461 466 10.1089/scd.2007.0083 17610376 (Pubitemid 47016231)
27. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Karussis D, Karageorgiou C, Vaknin-Dembinsky A, Gowda-Kurkalli B, Gomori JM, Kassis I, Bulte JW, Petrou P, Ben-Hur T, Abramsky O, Slavin S, Arch Neurol 2010 67 1187 1194 10.1001/archneurol.2010.248 20937945
28. Grafting of human bone marrow stromal cells into spinal cord injury: a comparison of delivery methods. Paul C, Samdani AF, Betz RR, Fischer I, Neuhuber B, Spine 2009 34 328 334 10.1097/BRS.0b013e31819403ce 19182705
29. Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS. Franz CK, Federici T, Yang J, Backus C, Oh SS, Teng Q, Carlton E, Bishop KM, Gasmi M, Bartus RT, Feldman EL, Boulis NM, Neurobiol Dis 2009 33 473 481 10.1016/j.nbd.2008.12.003 19135533
30. Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery. Snyder BR, Gray SJ, Quach ET, Huang JW, Leung CH, Samulski RJ, Boulis NM, Federici T, Hum Gene Ther 2011 22 1129 1135 10.1089/hum.2011.008 21443428
31. Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results. Knoller N, Auerbach G, Fulga V, Zelig G, Attias J, Bakimer R, Marder JB, Yoles E, Belkin M, Schwartz M, Hadani M, J Neurosurg Spine 2005 3 173 181 10.3171/spi.2005.3.3.0173 16235699
32. Safety of fetal olfactory ensheathing cell transplantation in patients with chronic spinal cord injury. A 38-month follow-up with MRI. Huang H, Chen L, Wang H, Xi H, Gou C, Zhang J, Zhang F, Liu Y, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2006 20 439 443 16683452
33. Influence of patients' age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury. Huang H, Chen L, Wang H, Xiu B, Li B, Wang R, Zhang J, Zhang F, Gu Z, Li Y, Song Y, Hao W, Pang S, Sun J, Chin Med J 2003 116 1488 1491 14570607 (Pubitemid 37461660)
34. Short-term outcome of olfactory ensheathing cells transplantation for treatment of amyotrophic lateral sclerosis. Chen L, Huang H, Zhang J, Zhang F, Liu Y, Xi H, Wang H, Gu Z, Song Y, Li Y, Tan K, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2007 21 961 966 17933231
35. Stem cell treatment in amyotrophic lateral sclerosis. Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Nasuelli N, Oggioni GD, Testa L, Fagioli F, J Neurol Sci 2008 265 78 83 10.1016/j.jns.2007.05.016 17582439
36. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Féron F, Perry C, Cochrane J, Licina P, Nowitzke A, Urquhart S, Geraghty T, Mackay-Sim A, Brain 2005 128 2951 2960 10.1093/brain/awh657 16219671 (Pubitemid 41746648)
37. Targeted spinal cord therapeutics delivery: stabilized platform and microelectrode recording guidance validation. Riley J, Butler J, Baker KB, McClelland S, Teng Q, Yang J, Garrity-Moses M, Federici T, Boulis NM, Stereotact Func Neurosurg 2008 86 67 74 10.1159/000112426 (Pubitemid 351341531)
38. Cervical spinal cord therapeutics delivery: preclinical safety validation of a stabilized microinjection platform. Riley J, Federici T, Park J, Suzuki M, Franz CK, Tork C, McHugh J, Teng Q, Svendsen C, Boulis NM, Neurosurgery 2009 65 754 761 discussion 761-762 10.1227/01.NEU.0000343524.45387.9E 19834381
39. Preclinical safety validation of a stabilized viral vector direct injection approach to the cervical spinal cord. Federici T, Riley J, Park J, Bain M, Boulis N, Clin Trans Sci 2009 2 165 167 10.1111/j.1752-8062.2008.00084.x
40. Cervical multilevel intraspinal stem cell therapy: assessment of surgical risks in Gottingen minipigs. Raore B, Federici T, Taub J, Wu MC, Riley J, Franz CK, Kliem MA, Snyder B, Feldman EL, Johe K, Boulis NM, Spine 2011 36 164 E171 10.1097/BRS.0b013e3181d77a47 21099736
41. Platform and cannula design improvements for spinal cord therapeutics delivery. Riley JP, Raore B, Taub JS, Federici T, Boulis NM, Neurosurgery 2011 69 ns147 ons154 discussion ons155 21471842
42. Translational stem cell therapy for amyotrophic lateral sclerosis. Boulis NM, Federici T, Glass JD, Lunn JS, Sakowski SA, Feldman EL, Nat Rev Neurol 2011 8 172 176 10.1038/nrneurol.2011.191 22158518
43. Stem celltechnology for the study and treatment of motor neuron diseases. Lunn JS, Sakowski SA, Federici T, Glass JD, Boulis NM, Feldman EL, Regen Med 2011 6 201 213 10.2217/rme.11.6 21391854
44. Translating stem cell studies to the clinic for CNS repair: current state of the art and the need for a Rosetta Stone. Aboody K, Capela A, Niazi N, Stern JH, Temple S, Neuron 2011 70 597 613 10.1016/j.neuron.2011.05.007 21609819
45. Inhibition of neurite outgrowth on astroglial scars in vitro. Rudge JS, Silver J, J Neurosci 1990 10 3594 3603 2230948
46. Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis. Suzuki M, Svendsen CN, Trends Neurosci 2008 31 192 198 10.1016/j.tins.2008.01.006 18329734
47. Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery. Lunn JS, Hefferan MP, Marsala M, Feldman EL, Growth Factors 2009 27 133 140 10.1080/08977190902814855 19294549
48. Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates. Behrstock S, Ebert A, McHugh J, Vosberg S, Moore J, Schneider B, Capowski E, Hei D, Kordower J, Aebischer P, Svendsen CN, Gene Ther 2006 13 379 388 10.1038/sj.gt.3302679 16355116
49. Lesioninduced increase in survival and migration of human neural progenitor cells releasing GDNF. Behrstock S, Ebert AD, Klein S, Schmitt M, Moore JM, Svendsen CN, Cell Transplant 2008 17 753 762 10.3727/ 096368908786516819 19044202
50. BDNF-, IGF-1- and GDNF-secreting human neural progenitor cells rescue amyloid betainduced toxicity in cultured rat septal neurons. Kitiyanant N, Kitiyanant Y, Svendsen CN, Thangnipon W, Neurochem Res 2011 37 143 152 21909955
51. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, Chen W, Zhai P, Sufit RL, Siddique T, Science 1994 264 1772 1775 10.1126/science.8209258 8209258 (Pubitemid 24227760)
52. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Howland DS, Liu J, She Y, Goad B, Maragakis NJ, Kim B, Erickson J, Kulik J, DeVito L, Psaltis G, DeGennaro LJ, Cleveland DW, Rothstein JD, Proc Natl Acad Sci USA 2002 99 1604 1609 10.1073/pnas.032539299 11818550 (Pubitemid 34136539)
53. Disease progression of human SOD1 (G93A) transgenic ALS model rats. Matsumoto A, Okada Y, Nakamichi M, Nakamura M, Toyama Y, Sobue G, Nagai M, Aoki M, Itoyama Y, Okano H, J Neurosci Res 2006 83 119 133 10.1002/jnr.20708 16342121 (Pubitemid 43062016)
54. Human neural stem cell grafts in the spinal cord of SOD1 transgenic rats: differentiation and structural integration into the segmental motor circuitry. Xu L, Ryugo DK, Pongstaporn T, Johe K, Koliatsos VE, J Comp Neurol 2009 514 297 309 10.1002/cne.22022 19326469
55. Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy. Pearn J, J Med Genet 1978 15 409 413 10.1136/jmg.15.6.409 745211 (Pubitemid 9093440)
56. Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy. Frugier T, Tiziano FD, Cifuentes-Diaz C, Miniou P, Roblot N, Dierich A, Le Meur M, Melki J, Hum Mol Genet 2000 9 849 858 10.1093/hmg/9.5.849 10749994 (Pubitemid 30162771)
57. Human motor neuron progenitor transplantation leads to endogenous neuronal sparing in 3 models of motor neuron loss. Wyatt TJ, Rossi SL, Siegenthaler MM, Frame J, Robles R, Nistor G, Keirstead HS, Stem Cells Int 2011 2011 207230 21716648
58. Histological and functional benefit following transplantation of motor neuron progenitors to the injured rat spinal cord. Rossi SL, Nistor G, Wyatt T, Yin HZ, Poole AJ, Weiss JH, Gardener MJ, Dijkstra S, Fischer DF, Keirstead HS, PLoS One 2010 5 11852 10.1371/journal.pone.0011852 20686613
59. Mesenchymal stem cells in health and disease. Uccelli A, Moretta L, Pistoia V, Nat Rev Immunol 2008 8 726 736 10.1038/nri2395 19172693
60. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Vercelli A, Mereuta OM, Garbossa D, Muraca G, Mareschi K, Rustichelli D, Ferrero I, Mazzini L, Madon E, Fagioli F, Neurobiol Dis 2008 31 395 405 10.1016/j.nbd.2008.05.016 18586098
61. Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients. Ferrero I, Mazzini L, Rustichelli D, Gunetti M, Mareschi K, Testa L, Nasuelli N, Oggioni GD, Fagioli F, Cell Transplant 2008 17 255 266 10.3727/096368908784153940 18522229 (Pubitemid 351717329)
62. Placement of deep brain stimulator electrodes using real-time high-field interventional magnetic resonance imaging. Martin AJ, Larson PS, Ostrem JL, Keith Sootsman W, Talke P, Weber OM, Levesque N, Myers J, Starr PA, Magn Reson Med 2005 54 1107 1114 10.1002/mrm.20675 16206144 (Pubitemid 41567189)
63. Interventional magnetic resonance guidance of deep brain stimulator implantation for Parkinson disease. Martin AJ, Larson PS, Ostrem JL, Starr PA, Top Magn Reson Imaging 2009 19 213 221 19148038
64. Imaging cardiac stem cell therapy: translations to human clinical studies. Zhang WY, Ebert AD, Narula J, Wu JC, J Cardiovasc Transl Res 2011 4 514 522 10.1007/s12265-011-9281-3 21538182
65. Stem cell tracking in human trials: a metaregression. McColgan P, Sharma P, Bentley P, Stem Cell Rev 2011 7 1031 1040 10.1007/s12015-011-9260-8 21475954
66. Long-term magnetic resonance imaging of stem cells in neonatal ischemic injury. Obenaus A, Dilmac N, Tone B, Tian HR, Hartman R, Digicaylioglu M, Snyder EY, Ashwal S, Annals Neurol 2011 69 282 291 10.1002/ana.22168
67. Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Guzman R, Uchida N, Bliss TM, He D, Christopherson KK, Stellwagen D, Capela A, Greve J, Malenka RC, Moseley ME, Palmer TD, Steinberg GK, Proc Natl Acad Sci USA 2007 104 10211 10216 10.1073/pnas.0608519104 17553967 (Pubitemid 47175288)
68. The use of cellular magnetic resonance imaging to track the fate of iron-labeled multipotent stromal cells after direct transplantation in a mouse model of spinal cord injury. Gonzalez-Lara LE, Xu X, Hofstetrova K, Pniak A, Chen Y, McFadden CD, Martinez-Santiesteban FM, Rutt BK, Brown A, Foster PJ, Mol Imaging Biol 2011 13 702 711 10.1007/s11307-010-0393-y 20686855
69. Tracking neural stem cells in patients with brain trauma. Zhu J, Zhou L, XingWu F, N Engl J Med 2006 355 2376 2378 10.1056/NEJMc055304 17135597 (Pubitemid 44837805)
70. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. de Vries IJ, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, Boerman OC, Oyen WJ, Bonenkamp JJ, Boezeman JB, Adema GJ, Bulte JW, Scheenen TW, Punt CJ, Heerschap A, Figdor CG, Nat Biotechnol 2005 23 1407 1413 10.1038/nbt1154 16258544 (Pubitemid 41679393)
71. Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Li Z, Suzuki Y, Huang M, Cao F, Xie X, Connolly AJ, Yang PC, Wu JC, Stem Cells 2008 26 864 873 10.1634/stemcells.2007-0843 18218820